154 related articles for article (PubMed ID: 38753221)
1. Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysis.
Wu M; Li C; Zhou X; Wu Z; Feng J; Guo X; Fang R; Lian Q; Pan M; Lai X; Peng Y
Inflammopharmacology; 2024 May; ():. PubMed ID: 38753221
[TBL] [Abstract][Full Text] [Related]
2. Wogonin Strengthens the Therapeutic Effects of Mesenchymal Stem Cells in DSS-Induced Colitis via Promoting IL-10 Production.
Wu Q; Xie S; Zhu Y; Chen J; Tian J; Xiong S; Wu C; Ye Y; Peng Y
Oxid Med Cell Longev; 2021; 2021():5527935. PubMed ID: 34239686
[TBL] [Abstract][Full Text] [Related]
3. TNFα and IFNγ rapidly activate PI3K-AKT signaling to drive glycolysis that confers mesenchymal stem cells enhanced anti-inflammatory property.
Xu C; Feng C; Huang P; Li Y; Liu R; Liu C; Han Y; Chen L; Ding Y; Shao C; Shi Y
Stem Cell Res Ther; 2022 Oct; 13(1):491. PubMed ID: 36195887
[TBL] [Abstract][Full Text] [Related]
4. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.
Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L
Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774
[TBL] [Abstract][Full Text] [Related]
5. The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through Glut1-mediated energy metabolic reprogramming.
Chen J; Xie S; Qiu D; Xie M; Wu M; Li X; Zhang X; Wu Q; Xiong Y; Wu C; Ren J; Peng Y
J Adv Res; 2023 Dec; ():. PubMed ID: 38070595
[TBL] [Abstract][Full Text] [Related]
6. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice.
Xu J; Wang X; Chen J; Chen S; Li Z; Liu H; Bai Y; Zhi F
Theranostics; 2020; 10(26):12204-12222. PubMed ID: 33204338
[No Abstract] [Full Text] [Related]
8. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
Front Immunol; 2018; 9():1078. PubMed ID: 29892282
[TBL] [Abstract][Full Text] [Related]
9. Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation.
Yang FY; Chen R; Zhang X; Huang B; Tsang LL; Li X; Jiang X
Cell Transplant; 2018 Sep; 27(9):1352-1367. PubMed ID: 30095002
[TBL] [Abstract][Full Text] [Related]
10. Wogonin improves colitis by activating the AhR pathway to regulate the plasticity of ILC3/ILC1.
Ye Q; Huang S; Wang Y; Chen S; Yang H; Tan W; Wu Z; Wang A; Chen Y
Phytomedicine; 2024 Jun; 128():155425. PubMed ID: 38518634
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of DSS-induced colitis in mice by TNF-α-stimulated mesenchymal stem cells derived from feline adipose tissue via COX-2/PGE
Kim K; An JH; Park SM; Lim G; Seo KW; Youn HY
J Vet Sci; 2023 Jul; 24(4):e52. PubMed ID: 37532297
[TBL] [Abstract][Full Text] [Related]
12. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice.
Song WJ; Li Q; Ryu MO; Nam A; An JH; Jung YC; Ahn JO; Youn HY
Res Vet Sci; 2019 Aug; 125():176-184. PubMed ID: 31247473
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.
Legaki E; Roubelakis MG; Theodoropoulos GE; Lazaris A; Kollia A; Karamanolis G; Marinos E; Gazouli M
Stem Cell Rev Rep; 2016 Oct; 12(5):604-612. PubMed ID: 27503204
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and acellular products attenuate murine induced colitis.
Li Y; Altemus J; Lightner AL
Stem Cell Res Ther; 2020 Nov; 11(1):515. PubMed ID: 33256827
[TBL] [Abstract][Full Text] [Related]
15. Pretreating mesenchymal stem cells with IL-6 regulates the inflammatory response of DSS-induced ulcerative colitis in rats.
Ding Q; Fang H; Jin P; Lv J; Ding S; Zhu W; Chen C
Transpl Immunol; 2023 Feb; 76():101765. PubMed ID: 36462558
[TBL] [Abstract][Full Text] [Related]
16. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
[TBL] [Abstract][Full Text] [Related]
17. Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease.
Fu Y; Ni J; Chen J; Ma G; Zhao M; Zhu S; Shi T; Zhu J; Huang Z; Zhang J; Chen J
Mol Ther; 2020 Apr; 28(4):1214-1228. PubMed ID: 32087149
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling.
Ye Y; Zhang X; Su D; Ren Y; Cheng F; Yao Y; Shi G; Ji Y; Chen S; Shi P; Dai L; Su X; Deng H
Stem Cell Res Ther; 2022 Sep; 13(1):465. PubMed ID: 36076306
[TBL] [Abstract][Full Text] [Related]
19. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models.
Yang H; Feng R; Fu Q; Xu S; Hao X; Qiu Y; Feng T; Zeng Z; Chen M; Zhang S
Cell Death Dis; 2019 Sep; 10(10):718. PubMed ID: 31558705
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells Ameliorate DSS-Induced Experimental Colitis by Modulating the Gut Microbiota and MUC-1 Pathway.
Wang H; Sun Y; Xiao FJ; Zhao X; Zhang WY; Xia YJ; Wang LS
J Inflamm Res; 2023; 16():2023-2039. PubMed ID: 37197438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
